Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Herpesvirus acquisition, epithelial replication, and odds of productive infection in vivo

EF 2014-15

Résumé
Epstein-Barr virus (EBV) is a type of herpes virus that infects almost everyone at a young age. Once a person is infected, the virus is with them for life, hidden in B cells of the immune system, called a latent infection. Often the initial infection is not even noticed, but sometimes it leads to infectious mononucleosis (commonly called “mono”) due the immune response against infected B cells. Mono causes fever, swollen lymph nodes, and prolonged fatigue, which makes EBV a major cause of missed work and school. Additionally, latent EBV infection has been linked to the development of several different forms of B cell cancers. Currently, there is no vaccine to prevent EBV infection. EBV infection is acquired by exposure to saliva of infected people. The virus first infects cells of the mouth and then gains access to B cells, which is where latent EBV infection persists. Recent studies by my supervisor, Dr. Soren Gantt, suggest that children with EBV infection in the mouth do not always develop a full infection with latency in B cells. In fact, it appears that only approximately 20% of saliva exposures lead to latent infection. In order to further understand how EBV establishes infection, a mouse version of this virus, gamma herpesvirus-68 (¿HV-68), will be used. I will determine how many ¿HV-68 particles are necessary to establish an infection that results in latency, and check whether ¿HV-68 can infect cells in the mouth without causing a latent infection, as we saw with EBV in children. I expect that ¿HV-68 infection will be a valuable model of initial infection with EBV, and will lead to discoveries that help to prevent EBV infection, mono and cancer.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
351459
Name
Simmons Karen
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Herpesvirus acquisition, epithelial replication, and odds of productive infection in vivo
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Epstein-Barr Virus; Herpesvirus; In Vivo Model; Infectious Disease; Vaccine Development; Virology
Abstract
Epstein-Barr virus (EBV) is a type of herpes virus that infects almost everyone at a young age. Once a person is infected, the virus is with them for life, hidden in B cells of the immune system, called a latent infection. Often the initial infection is not even noticed, but sometimes it leads to infectious mononucleosis (commonly called “mono”) due the immune response against infected B cells. Mono causes fever, swollen lymph nodes, and prolonged fatigue, which makes EBV a major cause of missed work and school. Additionally, latent EBV infection has been linked to the development of several different forms of B cell cancers. Currently, there is no vaccine to prevent EBV infection. EBV infection is acquired by exposure to saliva of infected people. The virus first infects cells of the mouth and then gains access to B cells, which is where latent EBV infection persists. Recent studies by my supervisor, Dr. Soren Gantt, suggest that children with EBV infection in the mouth do not always develop a full infection with latency in B cells. In fact, it appears that only approximately 20% of saliva exposures lead to latent infection. In order to further understand how EBV establishes infection, a mouse version of this virus, gamma herpesvirus-68 (¿HV-68), will be used. I will determine how many ¿HV-68 particles are necessary to establish an infection that results in latency, and check whether ¿HV-68 can infect cells in the mouth without causing a latent infection, as we saw with EBV in children. I expect that ¿HV-68 infection will be a valuable model of initial infection with EBV, and will lead to discoveries that help to prevent EBV infection, mono and cancer.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Simmons, Karen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~